Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
- 1 May 2015
- journal article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 3 (5), 382-391
- https://doi.org/10.1016/s2213-8587(15)00094-7
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Sugar, Sex, and TGF-β in Diabetic NephropathySeminars in Nephrology, 2012
- Sex Differences in the Development of Kidney Disease in Individuals With Type 1 Diabetes Mellitus: A Contemporary AnalysisAmerican Journal of Kidney Diseases, 2011
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesJournal of the American Society of Nephrology, 2009
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesThe New England Journal of Medicine, 2009
- Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)Diabetes Care, 2009
- Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and RetinopathyJAMA Internal Medicine, 2008
- Adverse renal consequences of obesityAmerican Journal of Physiology-Renal Physiology, 2008
- 17β-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signalingAmerican Journal of Physiology-Renal Physiology, 2007
- An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) StudyDiabetologia, 2004
- Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patientsDiabetologia, 1991